ENOV
Enovis Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -1.1% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 148.61K | $2.70M | n/a | n/a |
| Q2 2026 | 91 | +1 | 44.48M | $916.26M | +11 | −11 |
| Q1 2026 | 94 | 0 | 43.44M | $983.72M | +7 | −7 |
| Q4 2025 | 94 | 0 | 46.98M | $1.22B | +1 | −1 |
| Q3 2025 | 15 | 0 | 23.49M | $712.80M | +1 | −1 |
| Q2 2025 | 12 | -1 | 21.15M | $663.36M | +1 | −2 |
| Q1 2025 | 10 | -3 | 4.37M | $166.84M | +1 | −4 |
| Q4 2024 | 13 | +2 | 4.81M | $211.07M | +3 | −1 |
| Q3 2024 | 10 | 0 | 3.56M | $153.33M | +1 | −1 |
| Q2 2024 | 10 | n/a | 3.60M | $162.77M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 1.88M | -2.0% | $80.95M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 921.44K | +9.5% | $39.68M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Citadel Advisors ✦ | 273.77K | +97.7% | $11.79M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | T. Rowe Price ✦ | 252.75K | -31.9% | $10.88M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 5 | D. E. Shaw & Co. ✦ | 97.41K | -30.8% | $4.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | PRIMECAP Management ✦ | 85.30K | 0.0% | $3.67M | 0.0% | Held | 2 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 20.15K | +47.0% | $867,587 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 8 | Bridgewater Associates ✦ | 17.59K | +80.1% | $757,163 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | GAMCO Investors ✦ | 8.02K | -1.5% | $345,218 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 4.74K | New | $204,186 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Two Sigma Investments | $204,186 | 0.0% |
Exited
| Renaissance Technologies | $3.30M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 4 holders, 12.22M shares, $11.78M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer · Chief Administrative… · 2.66K sh @ 18.80 · $50,008
Officer, Director · Chief Executive… · 13.04K sh @ 19.15 · $249,620
Officer · Chief Administrative… · 5.14K sh @ 19.46 · $100,024
Officer · Chief Administrative… · 2.46K sh @ 20.32 · $49,947
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology